This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: atherosclerotic risk factors

News from the Cardiorenal Forum 12th Annual Scientific Meeting – Improving treatments in cardiorenal patients

March 2018

News from the Cardiorenal Forum 12th Annual Scientific Meeting – Improving treatments in cardiorenal patients

Fazlullah Wardak and Rosie Kalsi

Abstract

Do new diabetes drugs protect the heart and kidney? The day’s keynote session was given by Professor Johannes Mann (Friedrich Alexander University of Erlangen, Germany). Diabetes management has been transformed with the introduction of newer agents with the promise of cardiovascular and renal protection. The sodium glucose co-transporter-2 (SGLT-2) inhibitors are known to reduce the hyperfiltration, which occurs in early diabetic nephropathy. Glucagon-like peptide 1 (GLP-1) receptor agonists are incretin mimetics, which have several benefits for diabetes management. The mechanisms by which GLP-1 agonist therapy may reduce blood pressur

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now